Expert reports
Evidence
Documents containing the evidence that was used to develop the recommendations.
Supporting evidence
-
-
-
-
Economic analysis
-
Cost-effectiveness analysis of subsequent pharmacological therapy (PDF 2.49 MB)
-
-
-
Economic model report on continuous glucose monitoring in adults with type 2 diabetes (PDF 452 KB)
-
Health economic model report on treatments for type 2 diabetes (February 2022) (PDF 1.2 MB)
-
Other supporting evidence
-
-
-
Surveillance report
-
-
-
2019 surveillance of diabetes (NICE guidelines NG17, NG18, NG19 and NG28)
-
Appendix A1: Summary of evidence from surveillance (NG17) (PDF 1.2 MB)
-
Appendix B1: Stakeholder consultation comments table (NG17) (PDF 1.38 MB)
-
Appendix A2: Summary of evidence from surveillance (NG28) (PDF 1.86 MB)
-
Appendix B2: Stakeholder consultation comments table (NG28) (PDF 1.86 MB)
-
Appendix A3: Summary of evidence from surveillance (NG18) (PDF 992 KB)
-
Appendix B3: Stakeholder consultation comments table (NG18) (PDF 1.26 MB)
-
Appendix A4: Summary of evidence from surveillance (NG19) (PDF 746 KB)
-
Appendix B4: Stakeholder consultation comments table (NG19) (PDF 1.04 MB)
-
Evidence review
-
F1.1: Subsequent management (sections 1.1.1 to 1.1.6) (PDF 2.54 MB)
-
F1.2: Subsequent management (sections 1.1.7 to 1.1.14) (PDF 1.99 MB)
-
F2.1: Subsequent management (appendices A to C) (PDF 623 KB)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
F8.1: Subsequent management (references and appendices L to Q) (PDF 4.17 MB)
-
-
-
-
-
-
-
-
-
E1.1: Initial management (review and appendices A to C) (PDF 1.77 MB)
-
E1.2: Initial management (appendix D, studies A to K) (PDF 2.81 MB)
-
E1.3: Initial management (appendix D, studies L to Z) (PDF 2.48 MB)
-
-
-
-
-
-
C: Continuous glucose monitoring in adults with type 2 diabetes (PDF 2.01 MB)
-
-
-
A: SGLT2 inhibitors for people with chronic kidney disease and type 2 diabetes (PDF 3.27 MB)
-
-
Full guidance
-
-
Appendix A: Guideline development groups and declarations of interest (PDF 204 KB)
-
-
Appendix C: Search strategies and review protocols (PDF 423 KB)
-
Appendix D: GRADE tables and meta-analysis results (PDF 1.3 MB)
-
-
-
-
-
Appendix I: NICE guideline CG87 deleted appendix (PDF 3.89 MB)
-
-
-